- BNF:
- not assigned
- Status:
- Red
- Decision Date:
- July 2014
Comments
RED:1,2,3 NICE HST2 - For the treatment of mucopolysaccharidosis type IV (Morquio A syndrome) (Decision date - January 2016)
RED 1,2,3: NICE HST19 - for treating mucopolysaccharidosis type 4A. (Decision date - May 2022)
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
- 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
search again
